354 related articles for article (PubMed ID: 3396010)
21. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
22. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
24. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
26. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen].
Xu M
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
30. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
31. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.
Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D
Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
[TBL] [Abstract][Full Text] [Related]
34. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
35. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting.
Stein R; Chen S; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(4):1330-6. PubMed ID: 2153458
[TBL] [Abstract][Full Text] [Related]
36. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
[TBL] [Abstract][Full Text] [Related]
37. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
Ohuchi N; Simpson JF; Colcher D; Schlom J
Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
[TBL] [Abstract][Full Text] [Related]
39. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
[TBL] [Abstract][Full Text] [Related]
40. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
